|
Petteri Jarkka, Customer Engagement Manager at Janssen Nordic, talks to eyeforpharma about how the company is responding to recent calls for a ‘beyond the pill’ approach, and how they’re working with stakeholders to ‘co-create’ services improve health outcomes.
Several cancer metabolic expression changes have been discovered through a US study analysing gene expression data sourced from 22 types of tumours.
The Supreme Court heard a case on Tuesday which will decide whether generics firms can be held liable and sued over alleged design flaws in their medications.
The clinical trials systems and the governing regulations must change in order for the UK to remain an attractive site for conducting research, MPs heard from expert witnesses during an evidence hearing held last week before the House of Commons Science and Technology Committee.
Community programmes could be equally effective in the long term to clinical iniatives in preventing type II diabetes, a US study has recently highlighted
A life-changing, drug-resistant tuberculosis treatment option from J&J could give new hope to patients for the first time in 40 years.
The first computer model to predict several rather than a single cardiac mutation at a time could help us understand the real-world consequences of genetics and lifestyle to the heart for patients.
The European Parliament has ruled that urgent action to fight the number of deaths caused by the rising bacterial resistance to antimicrobial drugs.
The American Cancer Society estimates that about 123,000 new cases of melanoma are diagnosed in the US every year, however a group agencies are working to minimise future risk and improve treatments.
Petteri Jarkka, Customer Engagement Manager at Janssen Nordic, talks to eyeforpharma about how the...
EU citizens are unable to afford life-saving medication due to ongoing cuts and austerity measures...
Pharma firms are looking to collaborate with the right delivery device partners as a number of...
